Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(30%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
20%
Ph phase_3
2
20%
Ph phase_4
4
40%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
4(50.0%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(2)
Other(5)

Detailed Status

unknown4
Recruiting2
Completed2
Active, not recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (25.0%)
Phase 44 (50.0%)
N/A2 (25.0%)

Trials by Status

active_not_recruiting110%
suspended110%
recruiting220%
completed220%
unknown440%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10